Galatea Bio

About:

Galatea Bio’s mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.

Website: https://www.galatea.bio/

Top Investors: F-Prime Capital, Pareto Holdings, Edward Lando, Digitalis Ventures

Description:

Galatea Bio, a US-based biotechnology company was founder by Carlos Bustamante, Nicholas Katsanis and Alexander Ioannidis. Our mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics. Our passion is fueled by a focus on populations historically underrepresented in genetics research. We achieve this by leveraging our world-class clinical network and biobank, cutting-edge algorithms, and innovative analyses to discover and validate new tests, treatments, and cures that will improve the lives of all.

Total Funding Amount:

$20.7M

Headquarters Location:

Miami Lakes, Florida, United States

Founded Date:

2021-01-01

Founders:

Alexander Ioannidis, Carlos Bustamante, Nicholas Katsanis

Number of Employees:

11-50

Last Funding Date:

2024-09-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai